跳至主要内容
临床试验/NCT03210285
NCT03210285已完成不适用

Whole Exome Sequencing (WES) of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data

University Hospital Tuebingen1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2017年7月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
1
主要终点
Correlation clinical-volumetric pathologies and distinct genetic features

研究概览

简要总结

Whole exome sequencing (WES) of 50 sporadic and 50 Neurofibromatosis Type2 (NF2)-associated vestibularis schwannomas (VS) in children and young adults. The aim is to gain insight into the complete genome of the NF2 associated VS compared to sporadic VS (control group). These data are to be correlated with the clinic, ie the auditory function (audiogram, acoustically evoked potentials) and the clinical picture as well as the tumor growth rate and general data such as sex, age, side, etc.

详细描述

Whole exome sequencing (WES) of 50 sporadic and 50 Neurofibromatosis Type2 (NF2)-associated vestibularis schwannomas (VS) in children and young adults. The aim is to gain insight into the complete genome of the NF2 associated VS compared to sporadic VS (control group). These data are to be correlated with the clinic, ie the auditory function (audiogram, acoustically evoked potentials) and the clinical picture as well as the tumor growth rate and general data such as sex, age, side, etc.

The analysis of genetic changes should provide a better insight into the oncogenesis of these tumors. The distinct genetic characteristics between NF2-associated and sporadic VS suggest a different oncogenesis of these tumors.

The correlation of the genetic characteristics with the partly very different clinical appearance and a very different dynamics of the disease, in particular the tumor volume in the course, identifies the underlying modifiers of the disease course.

Based on these genetic modifiers, patients can be stratified and individual clinical therapy decisions can be made.

By demonstrating these genetic profiles in the peripheral blood, prospective conclusions can be drawn about expected disease progression before intervention as well as for therapy monitoring

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Other

入排标准

年龄范围
1 Day 至 99 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Study population: Operated NF2-associated VS
  • Control group: Operated sporadic VS
  • Consent to participation in the study by the patient / legal guardian in prospective inclusion or consent to the use of stored specimens in retrospective inclusion
  • Age: 0 -99 years

排除标准

  • Lack of informed consent
  • Patient's request (withdrawal of the consent statement for the evaluation of the data and further storage of the blood / tissue samples)

结局指标

主要结局

Correlation clinical-volumetric pathologies and distinct genetic features

时间窗: Within 1 week after measurement

Correlation between interindividually different clinical-volumetric pathologies and distinct genetic features

次要结局

  • Identification of genetic profiles for pre-interventional prediction of expected disease progression(Within 1 week after measurement)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验